UBS Group’s Precision BioSciences DTIL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$217K Sell
51,606
-5,421
-10% -$22.8K ﹤0.01% 5428
2025
Q1
$272K Sell
57,027
-11,588
-17% -$55.3K ﹤0.01% 5100
2024
Q4
$261K Buy
68,615
+66,732
+3,544% +$254K ﹤0.01% 5103
2024
Q3
$16.9K Buy
1,883
+1,676
+810% +$15K ﹤0.01% 6257
2024
Q2
$2.01K Buy
207
+1
+0.5% +$10 ﹤0.01% 7276
2024
Q1
$2.79K Sell
206
-2,752
-93% -$37.3K ﹤0.01% 6654
2023
Q4
$32.4K Buy
2,958
+300
+11% +$3.29K ﹤0.01% 5598
2023
Q3
$27.2K Buy
2,658
+497
+23% +$5.09K ﹤0.01% 5506
2023
Q2
$34.1K Buy
2,161
+2,056
+1,958% +$32.4K ﹤0.01% 5597
2023
Q1
$2.37K Sell
105
-505
-83% -$11.4K ﹤0.01% 7424
2022
Q4
$21.8K Buy
610
+486
+392% +$17.4K ﹤0.01% 6387
2022
Q3
$5K Buy
124
+86
+226% +$3.47K ﹤0.01% 8079
2022
Q2
$2K Hold
38
﹤0.01% 8487
2022
Q1
$4K Sell
38
-4,762
-99% -$501K ﹤0.01% 8227
2021
Q4
$1.07M Buy
4,800
+1,920
+67% +$426K ﹤0.01% 3397
2021
Q3
$997K Buy
2,880
+2,304
+400% +$798K ﹤0.01% 3260
2021
Q2
$217K Sell
576
-10,430
-95% -$3.93M ﹤0.01% 4265
2021
Q1
$3.42M Buy
11,006
+6,450
+142% +$2M ﹤0.01% 2284
2020
Q4
$1.14M Sell
4,556
-2,180
-32% -$545K ﹤0.01% 3053
2020
Q3
$1.25M Buy
6,736
+6,283
+1,387% +$1.16M ﹤0.01% 2781
2020
Q2
$114K Sell
453
-97
-18% -$24.4K ﹤0.01% 4383
2020
Q1
$100K Sell
550
-823
-60% -$150K ﹤0.01% 4433
2019
Q4
$572K Buy
1,373
+1,236
+902% +$515K ﹤0.01% 3789
2019
Q3
$34K Sell
137
-1,956
-93% -$485K ﹤0.01% 5456
2019
Q2
$832K Buy
2,093
+1,783
+575% +$709K ﹤0.01% 3174
2019
Q1
$167K Buy
+310
New +$167K ﹤0.01% 3966